Patents by Inventor Yuyong BA

Yuyong BA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIDINE DERIVATIVE AND APPLICATION THEREOF
    Publication number: 20230183221
    Abstract: Disclosed are a series of compounds having pyridine structures or pharmaceutically acceptable salts thereof, and an application thereof in the preparation of drugs for the treatment of related diseases. Specifically, disclosed is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 19, 2021
    Publication date: June 15, 2023
    Inventors: Yunfu LUO, Yuyong BA, Shuhui CHEN
  • Heterocycloalkyl compounds as CCR2 / CCR5 antagonists
    Publication number: 20230002360
    Abstract: The invention relates to a series of compounds with heterocycloalkyl, or isomers or pharmaceutically acceptable salts thereof, and to a use thereof in manufacturing a medicine of treatment CCR2/CCR5 antagonist-related diseases, specifically to a compound of Formula (I), or an isomer or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 24, 2020
    Publication date: January 5, 2023
    Inventors: Yunfu LUO, Yuyong BA, Yanhe CHEN, Shuhui CHEN
  • Biphenyl compound as CCR2/CCR5 receptor antagonist
    Patent number: 11155523
    Abstract: Provided is a CCR2/CCR5 receptor antagonist and the use thereof in the preparation of a drug for treating diseases associated with the CCR2/CCR5. In particular, disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: October 26, 2021
    Assignee: Medshine Discovery, Inc.
    Inventors: Yunfu Luo, Yuyong Ba, Shuhui Chen
  • Biphenyl Compound As CCR2/CCR5 Receptor Antagonist
    Publication number: 20200223801
    Abstract: Provided is a CCR2/CCR5 receptor antagonist and the use thereof in the preparation of a drug for treating diseases associated with the CCR2/CCR5. In particular, disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 11, 2017
    Publication date: July 16, 2020
    Inventors: Yunfu LUO, Yuyong BA, Shuhui CHEN